StockData
Opus Genetics, Inc. logo

Opus Genetics, Inc. (IRD) income statement

IRDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$4.08+0.16 (+4.08%)

Close on Nov 19, 2026Market cap $339.44MP/E –Yield –

See a number that looks wrong?